FFO
VERA icon

Fortitude Family Office’s Vera Therapeutics VERA Stock Holding History

Fortitude Family Office’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$336 – 2142
2025
Q1 		$336 Hold
14
– – ﹤0.01% 1097
2024
Q4 		$592 Hold
14
– – ﹤0.01% 1205
2024
Q3 		$619 Buy
+14
New +$531 ﹤0.01% 1147

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Fortitude Family Office's VERA Position: Q2 2025 in Review

Fortitude Family Office sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 14 shares — an estimated $336 sold.

Fortitude Family Office first reported a position in VERA in Q3 2024 and held it in 3 quarters. The position peaked at $619 in Q3 2024. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • Fortitude Family Office reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fortitude Family Office sold 14 Vera Therapeutics shares in Q2 2025, an estimated $336.
  • Fortitude Family Office first reported a position in Vera Therapeutics in Q3 2024 and held it in 3 quarters.
  • Fortitude Family Office's Vera Therapeutics position peaked at $619 in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on Fortitude Family Office's 13F filing for Q2 2025, filed 15 Jul 2025.